Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769637 · ClinicalTrials.gov registry record
Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02769637: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT02769637 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769637 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children with CF that are treated or untreated with acid blockade medication and to measure its possible impact on respiratory disease to develop novel treatment strategies.
Primary Outcome
Identification of bacterial communities and IL-8
Interventions
- DRUG PPI treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-09-07 |
| Est. Completion | 2018-01-18 |
Why NCT02769637 stopped before completion
NCT02769637 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PPI treatment is the first listed.
NCT02769637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769637 about?
NCT02769637 is a clinical study titled "Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)". Mucus in the airways of patients with CF represents an area for bacteria proliferation, microbial infection and inflammation. Similar to the lung, the esophagus provides an environment for bacterial to grow. The overall goal of this proposal is to characterize the esophageal microbiota of children w...
What is the current status of trial NCT02769637?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2017-09-07. Estimated completion is 2018-01-18.
What interventions are being tested in trial NCT02769637?
The interventions under investigation include: PPI treatment (DRUG).
Who is sponsoring clinical trial NCT02769637?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI